Somatostatin modulates insulin-degrading-enzyme metabolism: implications for the regulation of microglia activity in AD.
The deposition of β-amyloid (Aβ) into senile plaques and the impairment of somatostatin-mediated neurotransmission are key pathological events in the onset of Alzheimer's disease (AD). Insulin-degrading-enzyme (IDE) is one of the main extracellular protease targeting Aβ, and thus it represents...
Guardado en:
Autores principales: | Grazia Tundo, Chiara Ciaccio, Diego Sbardella, Mariaserena Boraso, Barbara Viviani, Massimiliano Coletta, Stefano Marini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/08e5ea94cdaf4e62b3cda27424c76a2c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Retention of Mitochondria in Mature Human Red Blood Cells as the Result of Autophagy Impairment in Rett Syndrome
por: Diego Sbardella, et al.
Publicado: (2021) -
Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
por: Elisa Vergari, et al.
Publicado: (2019) -
Nitrite-reductase and peroxynitrite isomerization activities of Methanosarcina acetivorans protoglobin.
por: Paolo Ascenzi, et al.
Publicado: (2014) -
No major role for insulin-degrading enzyme in antigen presentation by MHC molecules.
por: Slobodan Culina, et al.
Publicado: (2014) -
Medium-Chain Length Fatty Acids Enhance Aβ Degradation by Affecting Insulin-Degrading Enzyme
por: Janine Mett, et al.
Publicado: (2021)